High prolactin levels in dihydropteridine reductase deficiency: A sign of therapy failure or additional pathology?

Volume: 61, Issue: 1, Pages: 48 - 51
Published: Jun 29, 2021
Abstract
We report the case of a 22-year-old man with a diagnosis of dihydropteridine reductase (DHPR) deficiency who progressively developed movement disorders and epilepsy. Despite L-Dopa supplementation the patient continued to show high prolactin levels, with a discrepancy between the neurological clinical picture and the hormonal biochemical levels. For this reason, other potential causes were ruled out by performing a cerebral magnetic resonance...
Paper Details
Title
High prolactin levels in dihydropteridine reductase deficiency: A sign of therapy failure or additional pathology?
Published Date
Jun 29, 2021
Volume
61
Issue
1
Pages
48 - 51
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.